切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2020, Vol. 14 ›› Issue (03) : 281 -284. doi: 10.3877/cma.j.issn.1674-3946.2020.03.019

所属专题: 文献

论著

全胃切除术中经胰后入路清扫脾门淋巴结的安全性及可行性分析
蒲国士1,(), 张永娟1, 柏茂树1   
  1. 1. 635000 四川达州,达州市中西医结合医院
  • 收稿日期:2019-11-07 出版日期:2020-06-26
  • 通信作者: 蒲国士

Safety and feasibility of retropancreatic approach for splenic hilar lymph node dissection in laparoscopic total gastrectomy

Guoshi Pu1,(), Yongjuan Zhang1, Maoshu Bai1   

  1. 1. Dazhou Hospital of Integrated Traditional Chinese and Western Medicine, Sichuan DaZhou, 635000
  • Received:2019-11-07 Published:2020-06-26
  • Corresponding author: Guoshi Pu
  • About author:
    Corresponding author: Pu Guoshi, Email:
  • Supported by:
    Sichuan Natural Science Foundation Project(2017854621)
引用本文:

蒲国士, 张永娟, 柏茂树. 全胃切除术中经胰后入路清扫脾门淋巴结的安全性及可行性分析[J/OL]. 中华普外科手术学杂志(电子版), 2020, 14(03): 281-284.

Guoshi Pu, Yongjuan Zhang, Maoshu Bai. Safety and feasibility of retropancreatic approach for splenic hilar lymph node dissection in laparoscopic total gastrectomy[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2020, 14(03): 281-284.

目的

探究全胃切除术中经胰后入路清扫脾门淋巴结的安全性与可行性。

方法

回顾性分析2015年1月至2018年12月于腹腔镜下全胃切除且行脾门区淋巴结清扫保脾术的63例胃癌患者临床资料,将其分为左侧入路组患者33例,胰后入路组患者30例。采用统计软件SPSS 24.0进行数据分析,围术期指标、生活质量评分等计量资料采用(±s)表示,组间独立样本t检验;术后并发症等计数资料组间比较采用χ2检验;P<0.05差异有统计学意义。

结果

所有患者均成功完成手术,无中转切脾或中转开腹。胰后入路组在手术时间优于左侧入路组(P<0.05),而左侧入路组在术中出血量少于胰后入路组(P<0.05)。排气时间、术后住院时间及脾门淋巴结清扫数目差异均无统计学意义(P>0.05);左侧入路组患者并发症发生率为18.2%,胰后入路组为20%(P>0.05);两组患者术后6个月生活质量评分中的各项评分差异均无统计学意义(P>0.05)。

结论

腹腔镜胃癌根治术中,全胃切除经胰后入路清扫脾门淋巴结在术者对解剖结构良好的把握及规范操作下安全可行。

Objective

To study the safety and feasibility of retropancreatic approach for splenic hilar lymph node dissection in laparoscopic total gastrectomy.

Method

The clinical data of 63 patients with gastric cancer who underwent laparoscopic total gastrectomy and splenic hilar lymph node dissection from January 2015 to December 2018 were retrospectively analyzed. They were divided into left approach group (33 cases) and retropancreatic approach group (30 cases). Statistical software SPSS 24.0 was used for data analysis. The measurement data of perioperative indexes and quality of life scores of the two groups were (±s), and the independent sample t-test was used for comparison between groups. The count data of postoperative complications were n(%). The χ2 test was used for comparison between groups, and the rank sum test was used for classification of tumor stages. P<0.05 was the inspection standard.

Results

The operation was successfully completed in all patients without conversion to splenectomy or conversion to laparotomy. The operation time of the retropancreatic approach group was shorter than that of the left approach group (P<0.05), while the bleeding volume of the left approach group was lower than that of the retropancreatic approach group (P<0.05). There was no significant difference in exhaust time, hospital stay and the number of splenic hilar lymph node (P>0.05). The incidence of complications in the left approach group was 18.2%, while that in the retropancreatic approach group was 20%, there was no significant difference between the two groups (P>0.05). There was no significant difference in the scores of QOL between the two groups at 6 months after operation (P>0.05).

Conclusion

Laparoscopic radical total gastrectomy and splenic hilar lymph node dissection via retropancreatic approachis safe and feasible with good anatomical structure and standard operation.

表1 63例胃癌患者腹腔镜胃癌根治术不同入路两组患者基线资料比较[(±s),例]
表2 63例胃癌患者腹腔镜胃癌根治术不同入路两组患者围手术期指标(±s)
表3 63例胃癌患者腹腔镜胃癌根治术不同入路两组患者并发症发生情况(例)
表4 63例胃癌患者腹腔镜胃癌根治术不同入路两组患者QLQ-STO22生活质量评分(±s)
[1]
王宁,刘硕,杨雷,等.2018全球癌症统计报告解读[J/CD].肿瘤综合治疗电子杂志,2019,5(1):87-97.
[2]
季加孚,王宇宸,肖琪严.中国胃癌腹腔镜手术临床研究现状[J/CD].中华普外科手术学杂志(电子版),2019,13(2):109-113.
[3]
黄昌明,林建贤.腹腔镜胃癌根治术淋巴结清扫中团队配合的策略与技巧[J].中华消化外科杂志,2019,18(3):209-212.
[4]
中华医学会外科学分会腹腔镜与内镜外科学组.腹腔镜胃癌根治术手术入路选择专家共识[J].中国实用外科杂志,2017,37(4):412-414.
[5]
刘伟琳,杨舸,芮煜华,等.EORTC QLQ-STO22量表对我国胃癌患者有效性的验证[J].肿瘤研究与临床,2016,28(9):595-599.
[6]
何裕隆.腹腔镜根治手术在胃癌中应用的现状与争议[J/CD].中华普外科手术学杂志(电子版),2019,13(2):114-120.
[7]
Chen QY, Huang CM, Lin JX,et al,Laparoscopic Infrapyloric Area Lymph Node Dissection with No.14v Enlargement for Advanced Lower Gastric Cancer in Middle Colic Vein Approach[J].Ann Surg Oncol,2016,23(3):951.
[8]
Tsujiura M, Hiki N, Ohashi M,et al." Pancreas-Compressionless Gastrectomy" :A Novel Laparoscopic Approach for Suprapancreatic Lymph Node Dissection[J].Ann Surg Oncol,2017,24(11):3331-3337.
[9]
沈韧斌,徐伟.腹腔镜与开腹胃癌根治术对区域淋巴结清扫及并发症的影响比较[J/CD].中华普外科手术学杂志(电子版),2017,11(6):472-474.
[10]
日本胃癌學會.胃癌取扱い規約[M].15版. 東京:金原出版株式會社,2017.
[11]
沈阳,程元光,文刚.脾脏托出式脾门淋巴结清扫在中上部胃癌根治术中的应用[J].中华胃肠外科杂志,2017,20(1):108-109.
[12]
李红浪,胡林,李昌荣.腹腔镜中上部胃癌根治术中行脾门区淋巴结清扫研究进展[J].中国实用外科杂志,2015,35(2):223-226.
[13]
Sano T, Sasako M, Mizusawa J, et al. Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma[J].Ann Surg,2017,265(2):277-283.
[14]
黄昌明,林密.腹腔镜下脾门淋巴结清扫的技术要点--CLASS-04研究设计的初衷[J].中华胃肠外科杂志,2018,21(2):143-147.
[15]
梁寒.食管胃结合部腺癌的论断与治疗进展 [J].中华消化外科杂志,2016,15(1):1042-1047.
[16]
Carmona-Bayonas A, Jimenez-Fonseca P, Echavarrial I,et al.Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry[J].Eur J Surg Oncol,2018,44(8):1191-1198.
[17]
Neri A, Marrelli D, Voglino C,et al.Recurrence after surgery in esophago-gastric junctionadenocarcinoma: Current management and future perspectives[J].Surg Oncol,2016,25(4):355-363.
[1] 王佳佳, 詹韵韵, 姜凡, 孙碧云, 毕玉, 李如冰, 彭梅. Peyton四步教学法在超声住院医师规范化培训颈部淋巴结分区中的应用[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 814-818.
[2] 王杰, 袁泉, 王玥琦, 乔佳君, 谭春丽, 夏仲元, 刘守尧. 溃疡油在糖尿病足溃疡治疗中的应用效果及安全性观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 480-484.
[3] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[4] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[5] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[6] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[7] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[8] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[9] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[10] 韩戟, 杨力, 陈玉. 腹部形态CT参数与完全腹腔镜全胃切除术术中失血量的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 88-91.
[11] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[12] 庄宝雄, 邓海军. 单孔+1腹腔镜直肠癌侧方淋巴结清扫术[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 601-601.
[13] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[14] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[15] 王曦娅, 尹弘青, 丁伟, 徐滨, 于海源, 马东升, 邵军. 桥本背景下甲状腺乳头状癌多参数分析预测大容量淋巴结转移[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 548-554.
阅读次数
全文


摘要